These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 28178070)
1. Prolonged changes in amyloid-β metabolism after a severe traumatic brain injury. Bagnato S; Andriolo M; Boccagni C; Galardi G Neuroreport; 2017 Mar; 28(5):250-252. PubMed ID: 28178070 [TBL] [Abstract][Full Text] [Related]
2. Dissociation of cerebrospinal fluid amyloid-β and tau levels in patients with prolonged posttraumatic disorders of consciousness. Bagnato S; Andriolo M; Boccagni C; Sant'Angelo A; D'Ippolito ME; Galardi G Brain Inj; 2018; 32(8):1056-1060. PubMed ID: 29792528 [TBL] [Abstract][Full Text] [Related]
3. Marked increase of beta-amyloid(1-42) and amyloid precursor protein in ventricular cerebrospinal fluid after severe traumatic brain injury. Olsson A; Csajbok L; Ost M; Höglund K; Nylén K; Rosengren L; Nellgård B; Blennow K J Neurol; 2004 Jul; 251(7):870-6. PubMed ID: 15258792 [TBL] [Abstract][Full Text] [Related]
4. Prolonged Cerebrospinal Fluid Neurofilament Light Chain Increase in Patients with Post-Traumatic Disorders of Consciousness. Bagnato S; Grimaldi LME; Di Raimondo G; Sant'Angelo A; Boccagni C; Virgilio V; Andriolo M J Neurotrauma; 2017 Aug; 34(16):2475-2479. PubMed ID: 28385104 [TBL] [Abstract][Full Text] [Related]
5. Rapid amyloid-β oligomer and protofibril accumulation in traumatic brain injury. Abu Hamdeh S; Waara ER; Möller C; Söderberg L; Basun H; Alafuzoff I; Hillered L; Lannfelt L; Ingelsson M; Marklund N Brain Pathol; 2018 Jul; 28(4):451-462. PubMed ID: 28557010 [TBL] [Abstract][Full Text] [Related]
6. Alterations in cerebrospinal fluid apolipoprotein E and amyloid beta-protein after traumatic brain injury. Kay AD; Petzold A; Kerr M; Keir G; Thompson E; Nicoll JA J Neurotrauma; 2003 Oct; 20(10):943-52. PubMed ID: 14588111 [TBL] [Abstract][Full Text] [Related]
7. Self-reported traumatic brain injury and in vivo measure of AD-vulnerable cortical thickness and AD-related biomarkers in the ADNI cohort. Wang ML; Wei XE; Yu MM; Li PY; Li WB; Neurosci Lett; 2017 Aug; 655():115-120. PubMed ID: 28689050 [TBL] [Abstract][Full Text] [Related]
8. Monitoring of β-amyloid dynamics after human traumatic brain injury. Marklund N; Farrokhnia N; Hånell A; Vanmechelen E; Enblad P; Zetterberg H; Blennow K; Hillered L J Neurotrauma; 2014 Jan; 31(1):42-55. PubMed ID: 23829439 [TBL] [Abstract][Full Text] [Related]
9. Comparison of two different methods for measurement of amyloid-β peptides in cerebrospinal fluid after BACE1 inhibition in a dog model. Borghys H; Jacobs T; Van Broeck B; Dillen L; Dhuyvetter D; Gijsen H; Mercken M J Alzheimers Dis; 2014; 38(1):39-48. PubMed ID: 23948925 [TBL] [Abstract][Full Text] [Related]
10. Active duty service members who sustain a traumatic brain injury have chronically elevated peripheral concentrations of Aβ40 and lower ratios of Aβ42/40. Lejbman N; Olivera A; Heinzelmann M; Feng R; Yun S; Kim HS; Gill J Brain Inj; 2016; 30(12):1436-1441. PubMed ID: 27834544 [TBL] [Abstract][Full Text] [Related]
11. CSF and plasma amyloid-β temporal profiles and relationships with neurological status and mortality after severe traumatic brain injury. Mondello S; Buki A; Barzo P; Randall J; Provuncher G; Hanlon D; Wilson D; Kobeissy F; Jeromin A Sci Rep; 2014 Oct; 4():6446. PubMed ID: 25300247 [TBL] [Abstract][Full Text] [Related]
12. Traumatic brain injury accelerates amyloid-β deposition and impairs spatial learning in the triple-transgenic mouse model of Alzheimer's disease. Shishido H; Kishimoto Y; Kawai N; Toyota Y; Ueno M; Kubota T; Kirino Y; Tamiya T Neurosci Lett; 2016 Aug; 629():62-67. PubMed ID: 27373531 [TBL] [Abstract][Full Text] [Related]
13. Isobaric Quantification of Cerebrospinal Fluid Amyloid-β Peptides in Alzheimer's Disease: C-Terminal Truncation Relates to Early Measures of Neurodegeneration. Rogeberg M; Almdahl IS; Wettergreen M; Nilsson LN; Fladby T J Proteome Res; 2015 Nov; 14(11):4834-43. PubMed ID: 26452689 [TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid amyloid beta peptide patterns in Alzheimer's disease patients and nondemented controls depend on sample pretreatment: indication of carrier-mediated epitope masking of amyloid beta peptides. Bibl M; Esselmann H; Otto M; Lewczuk P; Cepek L; Rüther E; Kornhuber J; Wiltfang J Electrophoresis; 2004 Sep; 25(17):2912-8. PubMed ID: 15349929 [TBL] [Abstract][Full Text] [Related]